Brief: Somnomed Sees FY25 EBITDA Of More Than A$5 Million
28/08/2024 02:25
Aug 28 (Reuters) - Somnomed Ltd SOM.AX :
* SEES FY25 EBITDA OF MORE THAN A$5 MILLION
* SEES FY25 CAPEX OF BETWEEN A$3 MILLION AND A$4 MILLION
* SEES REVENUE OF APPROXIMATELY A$100 MILLION IN FY25
* TRADING IN FIRST 8 WEEKS OF FY25 HAS SEEN REVENUE UP 20%
YEAR-ON-YEAR
Further company coverage: SOM.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on SomnoMed
See all newsAustralia's Somnomed jumps most in 7 months on strong half-year earnings
Brief: Somnomed® Increases Investment In Managed Care Infrastructure
Australia's Somnomed hits 32-month high on upbeat revenue growth
Brief: Somnomed Says Q1 FY26 Revenue Up 13.5% To A$28.7 Million
Brief: Somnomed Says FY EBITDA AUD 9.2 Million